Adrenal tracer uptake by 18F-FDOPA PET/CT in patients with pheochromocytoma and controls

[1]  K. Pacak,et al.  Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  F. Borson‐Chazot,et al.  Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas , 2017, Nuclear medicine communications.

[3]  F. Borson‐Chazot,et al.  FDOPA Patterns in Adrenal Glands: A Pictorial Essay. , 2017, Clinical nuclear medicine.

[4]  R. Boellaard,et al.  Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment , 2017, Clinical nuclear medicine.

[5]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  D. Taïeb,et al.  Role of 18F‐FDOPA PET/CT imaging in endocrinology , 2014, Clinical endocrinology.

[7]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[8]  E. D. de Vries,et al.  Myocardial Metastases on 6-[18F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients , 2014, PloS one.

[9]  D. Rubello,et al.  Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging , 2013, Nuclear medicine communications.

[10]  F. Mottaghy,et al.  Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  E. D. de Vries,et al.  Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results. , 2009, Critical reviews in oncology/hematology.

[13]  J. Czernin,et al.  18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas , 2009, Journal of Nuclear Medicine.

[14]  Ronald Boellaard,et al.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  W. Oyen,et al.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  E. D. de Vries,et al.  Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. , 2007, Clinical chemistry.

[17]  Karel Pacak,et al.  Phaeochromocytoma , 2005, The Lancet.

[18]  D. Goldstein,et al.  Diagnostic Localization of Pheochromocytoma , 2002 .

[19]  H. Neumann,et al.  Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. , 2002, Radiology.

[20]  J. Carrasquillo,et al.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. , 2009, The Journal of clinical endocrinology and metabolism.

[21]  D. Goldstein,et al.  Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography. , 2002, Annals of the New York Academy of Sciences.